GLP-1 side effect anxiety: what the studies actually show

What did @mary_mack actually say?

She unboxed a compounded injectable, noted the label reads "5 milligrams per 0.5 milliliters" in a 5 mL bottle, and admitted she was initially confused because her prescribed dose is 10 mg. After reading her provider's instructions, she concluded the bottle contains "4 shots worth of 10 milligrams" and told viewers to keep it refrigerated.

To be clear, she was not prescribing a dose or recommending a protocol to her audience. She was describing her own prescription and her own confusion, which she resolved by reading her provider's paperwork. That framing matters. This is a first-person unboxing, not medical advice. That said, the math she walks through is worth checking, because a lot of viewers will assume her numbers apply to them too.

Does the science back this up?

The arithmetic is basically correct, and compounded tirzepatide vials are commonly dispensed this way. But the concentration she describes is not standardized, and that is a real issue worth saying plainly.

Tirzepatide, the active ingredient in Mounjaro and Zepbound, is a dual GIP and GLP-1 receptor agonist. The FDA-approved brand products come in prefilled, single-dose pens at fixed concentrations. Compounded versions do not. Compounding pharmacies configure multi-dose vials at varying concentrations, and patients draw doses manually using insulin syringes. At a concentration of 5 mg per 0.5 mL, that is 10 mg per mL, or 50 mg total in a 5 mL vial. Divided into 10 mg doses, yes, that gives you roughly 5 doses, not 4. The math she cited is slightly off, which we will address below. On the refrigeration instruction, she is correct. Tirzepatide peptides require cold chain storage, typically 2 to 8 degrees Celsius, consistent with manufacturer guidance.

What did they get wrong (or right)?

She got the concept right but fumbled the dose count. Here is where it breaks down: a 5 mL vial at 5 mg per 0.5 mL contains 50 mg total. At 10 mg per dose, that is 5 doses, not "4 shots worth" as she states. That is a minor error, but in a dosing context it is not trivial.

More importantly, compounded tirzepatide is not the same as FDA-approved tirzepatide. The FDA has repeatedly stated that compounded drugs are not FDA-approved and have not been evaluated for safety or efficacy in the same way as brand-name products. The agency placed tirzepatide on its shortage list, which temporarily permitted compounding under Section 503A and 503B, but that status has been updated over time. The FDA announced in late 2024 that the tirzepatide shortage had resolved, which affects the legal basis for compounding. Viewers watching this video should not assume compounded tirzepatide is interchangeable with Zepbound or Mounjaro. It is a different product from a regulatory standpoint, full stop.

She deserves credit for telling viewers to read their provider instructions rather than just eyeballing a dose. That is genuinely good advice.

What should you actually know?

If you are using or considering compounded tirzepatide, the concentration in your vial may be completely different from what she describes. There is no single standard. A vial labeled differently could contain a higher or lower concentration per milliliter, which changes how much volume you draw for a given dose. Getting this wrong is not a small mistake. Injecting the wrong volume of a peptide at the wrong concentration can mean a significant overdose or underdose.

The FDA issued warnings in 2024 about medication errors associated with compounded GLP-1 and GIP receptor agonist products, specifically citing patient confusion over units versus milligrams and variable concentrations across compounders. A 2023 analysis published by researchers at the University of Michigan noted that compounded semaglutide and tirzepatide products vary substantially in potency and purity across pharmacies (Becker et al., 2023, JAMA Internal Medicine). Always confirm your dose in volume, not just milligrams, with the pharmacy or your prescribing provider before injecting anything.

Bottom line

She handled the unboxing responsibly for a social media context. The refrigeration advice is correct. The encouragement to read provider instructions is correct. The dose count math is slightly off, and viewers need to understand that compounded tirzepatide is not equivalent to brand-name products. Concentration varies by pharmacy. If your vial looks different from hers, that does not mean something is wrong, but it does mean her numbers do not apply to you.